NorthStar Medical Radioisotopes, LLC and Convergent Therapeutics, Inc. Sign Strategic Contract Manufacturing Services Agreement Around CONV01-α
NorthStar Medical Radioisotopes, LLC and Convergent Therapeutics, Inc. Sign Strategic Contract Manufacturing Services Agreement Around CONV01-α
08/13/24, 12:12 PM
Location
beloitIndustry
medical device
medical
biotechnology
health care
Type
contract
NorthStar Medical Radioisotopes, LLC and Convergent Therapeutics, Inc. have announced the signing of a strategic contract manufacturing services agreement. This expanded collaboration will support clinical trials for CONV01-α, a prostate-specific membrane antigen (PSMA)-targeted monoclonal antibody linked to Ac-225, currently being investigated as a treatment for prostate cancer.
Company Info
Location
beloit, wisconsin, united states
Additional Info
NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, is a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases.